ArticleScientific reports2024
Highly efficient synthesis of pyrimidine-5-carbonitrile derivatives over a robust biowaste bone char-Bronsted solid acid catalyst.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In this study, the conversion of bones (waste of food industry) into bone char is described. The presence of calcium phosphate and graphitic carbon gives bone char unique properties, with different possible uses. The catalytic behavior of bone char modified with chlorosulfonic acid is tested as reusable and eco-friendly solid acid biocatalyst in synthesis of pyrimidine-5-carbonitrile derivatives. The catalyst properties were characterized by different techniques such as FT-IR, BET, SEM, TEM, TGA, EDS and XRD. The bone char catalyst can be reused several times without reducing catalyst efficiency. In addition to the various reported benefits, the first use of bone char as a catalyst support for organic synthesis is an important novelty of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.